Cancer Research Audrey Hepburn  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rinaldi, A. L.
Right arrow Articles by Mallery, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rinaldi, A. L.
Right arrow Articles by Mallery, S. R.
[Cancer Research 62, 5451-5456, October 1, 2002]
© 2002 American Association for Cancer Research


Biochemistry and Biophysics

Curcumin Activates the Aryl Hydrocarbon Receptor yet Significantly Inhibits (-)-Benzo(a)pyrene-7R-trans-7,8-dihydrodiol Bioactivation in Oral Squamous Cell Carcinoma Cells and Oral Mucosa1

Anthony L. Rinaldi2, Mark A. Morse, Henry W. Fields, David A. Rothas, Ping Pei, Kapila A. Rodrigo, Robert J. Renner and Susan R. Mallery3

College of Dentistry, Departments of Orthodontics and Oral Maxillofacial Surgery and Pathology [A. L. R., H. W. F., D. A. R., P. P., R. J. R., S. R. M.] and Division of Environmental Health Sciences, School of Public Health [M. A. M., K. A. R.], College of Medicine, Ohio State University, Columbus, Ohio, and The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 [M. A. M., S. R. M.]

The development of oral squamous cell carcinoma (SCC) shows a positive correlation with the carcinogen exposure that occurs during tobacco and alcohol use. The purpose of this study was to investigate whether the naturally occurring chemopreventive agent, curcumin, modulates expression and function of carcinogen- metabolizing enzymes in human keratinocytes isolated from oral SCC tumors. Dose-response studies demonstrated that curcumin concentrations of >=25 µM were cytotoxic for oral SCC cells. Curcumin increased both expression (reverse transcription-PCR analyses) and function (high-performance liquid chromatography determination of ethoxyresorufin metabolism) of cytochrome P-450 (CYP) 1A1 and/or CYP1B1. The aryl hydrocarbon receptor (AhR), which up-regulates a battery of genes associated with carcinogen metabolism, is activated by polycyclic aromatic hydrocarbons such as the tobacco-associated carcinogen benzo(a)pyrene. Electromobility shift assays demonstrated that similar to the established AhR ligand 2,3,7,8,-tetrachlorodibenzo-p-dioxin, curcumin inclusion resulted in AhR nuclear translocation and formation of the transcriptionally active AhR-aryl hydrocarbon receptor nuclear translocator complex. Cellular capacity to bioactivate the tobacco-associated carcinogen (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiodiol was determined by evaluating conversion of the carcinogenic metabolite diol epoxide to stable tetrols via high-performance liquid chromatography. Results of our metabolism studies showed that curcumin significantly inhibited CYP1A1-mediated benzo(a)pyrene diol bioactivation in both oral SCC cells and intact oral mucosa. Because CYP1A1 is one of the primary carcinogen-activating enzymes in oral mucosa, the use of curcumin as an oral cavity chemopreventive agent could have significant clinical impact via its ability to inhibit carcinogen bioactivation.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Balasubramanian and R. L. Eckert
Curcumin Suppresses AP1 Transcription Factor-dependent Differentiation and Activates Apoptosis in Human Epidermal Keratinocytes
J. Biol. Chem., March 2, 2007; 282(9): 6707 - 6715.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-H. Kim, E. C. Henry, D.-K. Kim, Y.-H. Kim, K. J. Shin, M. S. Han, T. G. Lee, J.-K. Kang, T. A. Gasiewicz, S. H. Ryu, et al.
Novel Compound 2-Methyl-2H-pyrazole-3-carboxylic Acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) Prevents 2,3,7,8-TCDD-Induced Toxicity by Antagonizing the Aryl Hydrocarbon Receptor
Mol. Pharmacol., June 1, 2006; 69(6): 1871 - 1878.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Choudhuri, S. Pal, T. Das, and G. Sa
Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-expressed Cells at G2 Phase of Cell Cycle in a p53-dependent Manner
J. Biol. Chem., May 20, 2005; 280(20): 20059 - 20068.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.